Streetbeat News

Stock Prices

AMAT

Over the past 5 years, Applied Materials (NASDAQ:AMAT) has produced an average annual return of 34.86%, outperforming the market by 21.86%. A $100 investment in AMAT 5 years ago would be worth $434.27 today. The company's market capitalization currently stands at $124.58 billion.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

INTU

Over the past 15 years, Intuit (NASDAQ:INTU) has delivered an average annual return of 24.21%, outperforming the market by 12.01% on an annualized basis. A $1000 investment in Intuit 15 years ago would be worth $25,086.07 today. Intuit's market capitalization currently stands at $168.89 billion.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

SAP

SAP Inc. (NYSE:SAP) shares are trading at $152.32, with a 0.15% drop in the current session and a 3.75% decrease over the past month, despite a 32.61% increase over the past year. The company's P/E ratio of 76.2 is lower than the Software industry average of 148.83, which could suggest that SAP is undervalued or that shareholders expect less future growth. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

Unity Software has announced a reduction in its workforce, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:59 pm

SRPT

Sarepta Therapeutics Inc (NASDAQ:SRPT) reported preliminary FY23 net product revenue of $1.145 billion, with Q4 Elevidys revenue at $131.3 million and FY23 at $200.4 million, surpassing consensus. RNA-based PMOs revenue for Q4 and FY23 are expected at $234.3 million and $945.0 million, respectively. The company has $1.7 billion in cash and investments. Wedbush maintains an Outperform rating on SRPT with a price target of $224, citing significant patient demand for Elevidys and potential label expansion for Duchenne muscular dystrophy treatment. SRPT shares rose 9.77% to $112.64.

Portfolio Pulse from Vandana Singh

January 09, 2024 | 5:58 pm

NVO

Novo Nordisk's CEO anticipates a substantial increase in WEGOVY volumes in 2024. This expectation is based on the company's confidence in the product's market demand and potential growth. WEGOVY is a medication designed for weight management, and its increased volumes could signal a positive outlook for Novo Nordisk's revenue and market share in the weight management sector.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:54 pm

ARKK

RXRX

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stock has risen over 80% in the past month and is one of today's biggest movers after unveiling its new software, LOWE, at the J.P. Morgan Healthcare Conference. LOWE is designed to perform complex drug discovery tasks using a natural language interface. Additionally, Recursion recently in-licensed a new chemical entity from Bayer AG for fibrosis treatment and was added to the ARK Innovation ETF (NYSE:ARKK) portfolio.

Portfolio Pulse from Erica Kollmann

January 09, 2024 | 5:54 pm

NTNX

Traders are circulating a rumor from an M&A research blog that Nutanix, Inc. (NTNX) has received a buyout offer. The source and details of the offer have not been confirmed.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:44 pm

AAPL

IBM

INTC

META

QCOM

TSLA

TSM

Samsung Electronics topped the U.S. patent recipient list for 2023 with 6,165 patents, followed by Qualcomm, TSMC, and IBM. Apple, Micron, and Intel were also in the top 10, while Meta and Tesla were notably absent. The patent landscape shows growth in autonomous driving, electrical smoking devices, quantum computing, breathing masks, and nanotechnology. U.S. patents issued decreased by 3.4% in 2023, with U.S. companies securing nearly half of all patents. Japan and South Korea are also significant recipients, despite declines.

Portfolio Pulse from Surbhi Jain

January 09, 2024 | 5:40 pm

ABL

AFGE

BHFAP

EHTH

HRTG

JRVR

KMPB

LMND

PRA

RELI

ROOT

TIPT

In Tuesday's intraday session, insurance stocks saw notable movements. Gainers included Reliance Global Group (RELI), eHealth (EHTH), Kemper Corporation Debentures (KMPB), Brighthouse Financial (BHFAP), Heritage Insurance Holdings (HRTG), and American Financial Group Debentures (AFGE). Losers comprised James River Group Holdings (JRVR), Abacus Life (ABL), ProAssurance (PRA), Root (ROOT), Tiptree (TIPT), and Lemonade (LMND). The movements were reported with respective changes in stock prices and trading volumes, which were at 0% of their average full-day volumes over the last 100 days.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 5:40 pm